Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers

This is a clinical practice guideline for asymptomatic survivors of childhood, adolescent, or young adult cancers who present for routine exposure-related medical follow-up. The guidelines are intended to be used 2 or more years after the completion of cancer therapy, and present recommendations on screening and management of late effects resulting from therapeutic exposures used during treatment for pediatric malignancies. Outcomes of interest include risk and type of long-term complications, and efficacy of screening for and treatment of these complications.